BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 7848896)

  • 1. Short and long-acting oral nitrates for stable angina pectoris.
    Thadani U; Lipicky RJ
    Cardiovasc Drugs Ther; 1994 Aug; 8(4):611-23. PubMed ID: 7848896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal nitrate therapy with a once-daily sustained-release formulation of isosorbide mononitrate.
    Waller DG
    J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 2():S21-7; discussion S29-31. PubMed ID: 10499557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure.
    Thadani U
    Cardiovasc Drugs Ther; 1997 Jan; 10(6):735-42. PubMed ID: 9110117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness?
    Rudolph W; Dirschinger J; Reiniger G; Beyerle A; Hall D
    Eur Heart J; 1988 Jan; 9 Suppl A():63-72. PubMed ID: 3137072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study.
    Savonitto S; Motolese M; Agabiti-Rosei E
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):194-203. PubMed ID: 7620688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-ischaemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: when does cross-tolerance occur?
    Kośmicki MA; Szwed H; Sadowski Z
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):47-55. PubMed ID: 15115903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.
    Silber S
    Eur J Clin Pharmacol; 1990; 38 Suppl 1():S35-51. PubMed ID: 2113003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of isosorbide mononitrate in angina pectoris.
    Thadani U; de Vane PJ
    Am J Cardiol; 1992 Nov; 70(17):67G-71G. PubMed ID: 1449103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrates for angina pectoris. A critical review of therapeutic efficacy and tolerance.
    Thadani U
    Herz; 1984 Jun; 9(3):123-36. PubMed ID: 6430766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma volume expansion may explain the attenuation of antianginal activity of oral isosorbide dinitrate in long-term therapy].
    Kośmicki M; Sadowski Z
    Pol Arch Med Wewn; 1999 Nov; 102(5):967-72. PubMed ID: 11072531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrate cross-tolerance: effect of sublingual isosorbide dinitrate and nitroglycerin during sustained nitrate therapy.
    Dalal JJ; Parker JO
    Am J Cardiol; 1984 Aug; 54(3):286-8. PubMed ID: 6431795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
    Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
    Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrate tolerance.
    Parker JO
    Am J Cardiol; 1985 Dec; 56(17):28I-31I. PubMed ID: 3934952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrate tolerance. A problem during continuous nitrate administration.
    Parker JO
    Eur J Clin Pharmacol; 1990; 38 Suppl 1():S21-5. PubMed ID: 2113001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
    Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
    Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained effect of and lack of development of tolerance to controlled-release isosorbide-5-mononitrate in chronic stable angina pectoris.
    Wisenberg G; Roks C; Nichol P; Goddard MD
    Am J Cardiol; 1989 Sep; 64(10):569-76. PubMed ID: 2782247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrate therapy for stable angina pectoris.
    Parker JD; Parker JO
    N Engl J Med; 1998 Feb; 338(8):520-31. PubMed ID: 9468470
    [No Abstract]   [Full Text] [Related]  

  • 18. Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration.
    Abrams J
    Drugs; 1987 Sep; 34(3):391-403. PubMed ID: 3119308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
    Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE
    Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained hemodynamic and antianginal effects of high dose oral isosorbide dinitrate.
    Aronow S
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2483-6. PubMed ID: 7422537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.